Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Scharnitz

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Family Physician|May 14, 2016
Annular Scaly PlaquesElizabeth Seiverling, Galen Foulke, Thomas Scharnitz
JAAD International|October 2, 2023
High rate of incidental detection of skin cancer following teledermatology consultation: Full body skin examination may detect more skin cancers than a referral-based approachTrilokraj Tejasvi, Nicole Trupiano, Thomas Scharnitz, et al.
Dermatology Research and Practice|October 10, 2015
Actinic Keratosis Clinical Practice Guidelines: An Appraisal of QualityJoslyn S Kirby, Thomas Scharnitz, Elizabeth V Seiverling, et al.
American Journal of Cancer Research|February 13, 2023
The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral centerThomas Scharnitz, Mio Nakamura, Erika Koeppe, et al.
JAAD Case Reports|April 8, 2020
Iodine toxicity after iodinated contrast: New observations in iododermaMason Runge, Kiyanna Williams, Thomas Scharnitz, et al.
Dermatology and Therapy|February 7, 2025
Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis TrialsJoseph F Merola, Laura K Ferris, Jeffrey M Sobell, et al.
Dermatology and Therapy|March 21, 2025
Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis TrialsApril W Armstrong, Leon Kircik, Linda Stein Gold, et al.
Journal of Clinical Immunology|December 20, 2019
A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related DiseasesTaylor Novice, Amina Kariminia, Kate L Del Bel, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Family Physician|May 14, 2016
Annular Scaly PlaquesElizabeth Seiverling, Galen Foulke, Thomas Scharnitz
JAAD International|October 2, 2023
High rate of incidental detection of skin cancer following teledermatology consultation: Full body skin examination may detect more skin cancers than a referral-based approachTrilokraj Tejasvi, Nicole Trupiano, Thomas Scharnitz, et al.
Dermatology Research and Practice|October 10, 2015
Actinic Keratosis Clinical Practice Guidelines: An Appraisal of QualityJoslyn S Kirby, Thomas Scharnitz, Elizabeth V Seiverling, et al.
American Journal of Cancer Research|February 13, 2023
The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral centerThomas Scharnitz, Mio Nakamura, Erika Koeppe, et al.
JAAD Case Reports|April 8, 2020
Iodine toxicity after iodinated contrast: New observations in iododermaMason Runge, Kiyanna Williams, Thomas Scharnitz, et al.
Dermatology and Therapy|February 7, 2025
Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis TrialsJoseph F Merola, Laura K Ferris, Jeffrey M Sobell, et al.
Dermatology and Therapy|March 21, 2025
Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis TrialsApril W Armstrong, Leon Kircik, Linda Stein Gold, et al.
Journal of Clinical Immunology|December 20, 2019
A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related DiseasesTaylor Novice, Amina Kariminia, Kate L Del Bel, et al.
Pageof 1